{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:34:35Z","timestamp":1790832875832,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.ando.2016.02.003","type":"journal-article","created":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T10:16:33Z","timestamp":1462875393000},"page":"192-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["SFE\/SFHTA\/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic steps"],"prefix":"10.1016","volume":"77","author":[{"given":"Claire","family":"Douillard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Houillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juerg","family":"Nussberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Girerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2016.02.003_bib0430","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1445-5994.1976.tb03306.x","article-title":"Outpatient screening tests for primary aldosteronism","volume":"6","author":"Dunn","year":"1976","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.ando.2016.02.003_bib0435","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","article-title":"A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients","volume":"141","author":"Hiramatsu","year":"1981","journal-title":"Arch Internal Med"},{"key":"10.1016\/j.ando.2016.02.003_bib0440","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/00004872-200311000-00025","article-title":"High rate of detection of primary aldosteronism, including surgically treatable forms, after \u2018non-selective\u2019 screening of hypertensive patients","volume":"21","author":"Stowasser","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.ando.2016.02.003_bib0445","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1210\/jcem-73-5-952","article-title":"Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism","volume":"73","author":"McKenna","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.02.003_bib0450","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1210\/jc.2004-1149","article-title":"The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling","volume":"90","author":"Tiu","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.02.003_bib0455","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/HJH.0b013e3282f61f8c","article-title":"Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism","volume":"26","author":"Bernini","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.ando.2016.02.003_bib0460","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.acvd.2012.07.006","article-title":"Aldosterone-to-renin ratio for diagnosing aldosterone-producing adenoma: a multicentre study","volume":"105","author":"Ducher","year":"2012","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.ando.2016.02.003_bib0465","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mce.2003.10.006","article-title":"Primary aldosteronism\u2013careful investigation is essential and rewarding","volume":"217","author":"Stowasser","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ando.2016.02.003_bib0470","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/HYPERTENSIONAHA.109.139832","article-title":"Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism","volume":"55","author":"Rossi","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ando.2016.02.003_bib0475","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1210\/jc.2002-021476","article-title":"Variability in the renin\/aldosterone profile under random and standardized sampling conditions in primary aldosteronism","volume":"88","author":"Tanabe","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.02.003_bib0480","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ancard.2015.04.017","article-title":"Effect of postural changes on aldosterone to plasma renin ratio in patients with suspected secondary hypertension","volume":"64","author":"Barigou","year":"2015","journal-title":"Ann Cardiol Angeiol"},{"key":"10.1016\/j.ando.2016.02.003_bib0485","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1750-1172-5-9","article-title":"Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism","volume":"5","author":"Amar","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ando.2016.02.003_bib0490","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.02.003_bib0495","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","article-title":"Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample","volume":"49","author":"Newton-Cheh","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ando.2016.02.003_bib0500","doi-asserted-by":"crossref","first-page":"83s","DOI":"10.1016\/S0753-3322(00)80019-0","article-title":"Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital","volume":"54","author":"Nishikawa","year":"2000","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ando.2016.02.003_bib0505","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0895-7061(02)02969-2","article-title":"High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives","volume":"15","author":"Rossi","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ando.2016.02.003_bib0510","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1125\u00a0hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ando.2016.02.003_bib0515","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1291\/hypres.30.111","article-title":"Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone\/renin ratio above 25 as a screening test","volume":"30","author":"Fogari","year":"2007","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ando.2016.02.003_bib0520","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","article-title":"Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study","volume":"371","author":"Douma","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2016.02.003_bib0525","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-0031-1295460","article-title":"Factors affecting the aldosterone\/renin ratio","volume":"44","author":"Stowasser","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ando.2016.02.003_bib0530","first-page":"E43","article-title":"Aldosterone release during the sleep-wake cycle in humans","volume":"276","author":"Charloux","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ando.2016.02.003_bib0535","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/ajh.2008.175","article-title":"Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas","volume":"21","author":"Mourad","year":"2008","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ando.2016.02.003_bib0540","doi-asserted-by":"crossref","first-page":"e67417","DOI":"10.1371\/journal.pone.0067417","article-title":"Comparison of 24-h urinary aldosterone level and random urinary aldosterone-to-creatinine ratio in the diagnosis of primary aldosteronism","volume":"8","author":"Wu","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ando.2016.02.003_bib0545","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s12020-013-0028-6","article-title":"NT-proBNP, a useful tool in hypertensive patients undergoing a diagnostic evaluation for primary aldosteronism","volume":"45","author":"Pizzolo","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2016.02.003_bib0550","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jc.2014-3663","article-title":"Update in primary aldosteronism","volume":"100","author":"Stowasser","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.02.003_bib0555","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cca.2006.03.034","article-title":"Simultaneous determination of 12 steroids by isotope dilution liquid chromatography-photospray ionization tandem mass spectrometry","volume":"372","author":"Guo","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ando.2016.02.003_bib0560","first-page":"113","article-title":"Determination of aldosterone in serum by liquid chromatography-tandem mass spectrometry","volume":"862","author":"Turpeinen","year":"2008","journal-title":"J Chromatogr"},{"key":"10.1016\/j.ando.2016.02.003_bib0565","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1373\/clinchem.2008.116004","article-title":"Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry","volume":"55","author":"Taylor","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.ando.2016.02.003_bib0570","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.cca.2014.07.036","article-title":"Performance enhancement in the measurement of 5 endogenous steroids by LC-MS\/MS combined with differential ion mobility spectrometry","volume":"438","author":"Ray","year":"2014","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ando.2016.02.003_bib0575","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cca.2014.03.015","article-title":"Combination of LC-MS\/MS aldosterone and automated direct renin in screening for primary aldosteronism","volume":"433","author":"Juutilainen","year":"2014","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ando.2016.02.003_bib0580","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.02.003_bib0585","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/HJH.0b013e3283479cfc","article-title":"Methodological remarks about plasma renin assays","volume":"29","author":"Sala","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.ando.2016.02.003_bib0590","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00004872-200402000-00023","article-title":"Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism","volume":"22","author":"Ferrari","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.ando.2016.02.003_bib0595","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0039-128X(96)00007-4","article-title":"Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure","volume":"61","author":"Oelkers","year":"1996","journal-title":"Steroids"},{"key":"10.1016\/j.ando.2016.02.003_bib0600","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1530\/eje.0.1500517","article-title":"Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal mass","volume":"150","author":"Unger","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2016.02.003_bib0605","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.beem.2010.10.007","article-title":"Primary aldosteronism: what consensus for the diagnosis","volume":"24","author":"Cicala","year":"2010","journal-title":"Best Pract Res"},{"key":"10.1016\/j.ando.2016.02.003_bib0610","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.clinbiochem.2012.06.025","article-title":"Progestin-dependent effect of oral contraceptives on plasma aldosterone\/renin ratio","volume":"45","author":"Locsei","year":"2012","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ando.2016.02.003_bib0615","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1177\/1470320313519487","article-title":"The ratios of aldosterone\/plasma renin activity (ARR) versus aldosterone\/direct renin concentration (ADRR)","volume":"16","author":"Glinicki","year":"2015","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.ando.2016.02.003_bib0620","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/01.hjh.0000174968.72212.ac","article-title":"Resistant hypertension","volume":"23","author":"Kaplan","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.ando.2016.02.003_bib0625","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/01.hjh.0000217857.20241.0f","article-title":"Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol","volume":"24","author":"Giacchetti","year":"2006","journal-title":"J Hypertens"},{"key":"10.1016\/j.ando.2016.02.003_bib0630","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1080\/10641960802443282","article-title":"The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine","volume":"30","author":"Niizuma","year":"2008","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.ando.2016.02.003_bib0635","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11154-011-9160-x","article-title":"Primary aldosteronism: a contrarian view","volume":"12","author":"Kaplan","year":"2011","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.ando.2016.02.003_bib0640","first-page":"526","article-title":"Assay characteristics influence the aldosterone to renin ratio as a screening tool for primary aldosteronism: results of the German Conn's registry","volume":"45","author":"Fischer","year":"2011","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ando.2016.02.003_bib0645","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0889-8529(02)00013-0","article-title":"Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature","volume":"31","author":"Montori","year":"2002","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.ando.2016.02.003_bib0650","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High incidence of primary aldosteronism in 199 patients referred with hypertension","volume":"21","author":"Gordon","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.ando.2016.02.003_bib0655","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.jhh.1001013","article-title":"High prevalence of primary aldosteronism in the Tayside hypertension clinic population","volume":"14","author":"Lim","year":"2000","journal-title":"J Human Hypertens"},{"key":"10.1016\/j.ando.2016.02.003_bib0660","first-page":"2854","article-title":"Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore","volume":"85","author":"Loh","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.02.003_bib0665","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1055\/s-0032-1301894","article-title":"One-hour upright posture is an ideal position for serum aldosterone concentration and plasma renin activity measuring on primary aldosteronism screening","volume":"120","author":"Yin","year":"2012","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.ando.2016.02.003_bib0670","first-page":"1238","article-title":"[Conn's adenoma. Diagnostic and prognostic value of the measurement of potassium, renin, aldosterone levels and the aldosterone\/renin ratio]","volume":"24","author":"Massien-Simon","year":"1995","journal-title":"Presse Med"},{"key":"10.1016\/j.ando.2016.02.003_bib0675","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/ndt\/gfh112","article-title":"Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension","volume":"19","author":"Plouin","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ando.2016.02.003_bib0680","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","article-title":"Primary aldosteronism: renaissance of a syndrome","volume":"66","author":"Young","year":"2007","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2016.02.003_bib0685","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1373\/clinchem.2011.165662","article-title":"Reference values for aldosterone-renin ratios in normotensive individuals and effect of changes in dietary sodium consumption","volume":"57","author":"Kerstens","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.ando.2016.02.003_bib0690","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1046\/j.1440-1681.2001.03585.x","article-title":"Is primary aldosteronism underdiagnosed in clinical practice?","volume":"28","author":"Fiquet-Kempf","year":"2001","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.ando.2016.02.003_bib0695","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3317\/jraas.2001.022","article-title":"Diagnosis and management of primary aldosteronism","volume":"2","author":"Stowasser","year":"2001","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.ando.2016.02.003_bib0700","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF03349761","article-title":"Primary aldosteronism","volume":"18","author":"Gordon","year":"1995","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2016.02.003_bib0705","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.jhh.1001948","article-title":"Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia","volume":"20","author":"Williams","year":"2006","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.ando.2016.02.003_bib0710","first-page":"947","article-title":"Effect of aging on renin activity and aldosterone excretion","volume":"87","author":"Crane","year":"1976","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.ando.2016.02.003_bib0715","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/jhh.2015.21","article-title":"Potential effects of age on screening for primary aldosteronism","volume":"30","author":"Luo","year":"2016","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.ando.2016.02.003_bib0720","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1210\/jc.2002-022051","article-title":"Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing, and adrenal vein sampling","volume":"88","author":"Espiner","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.02.003_bib0725","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1172\/JCI105464","article-title":"A diurnal rhythm in plasma renin activity in man","volume":"45","author":"Gordon","year":"1966","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ando.2016.02.003_bib0730","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00004872-200402000-00006","article-title":"The challenge of more robust and reproducible methodology in screening for primary aldosteronism","volume":"22","author":"Gordon","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.ando.2016.02.003_bib0735","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/jhh.2008.109","article-title":"The ovarian cycle as a factor of variability in the laboratory screening for primary aldosteronism in women","volume":"23","author":"Fommei","year":"2009","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.ando.2016.02.003_bib0740","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1210\/jcem-28-9-1269","article-title":"Aldosterone secretory rates in the normal menstrual cycle","volume":"28","author":"Gray","year":"1968","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.02.003_bib0745","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1210\/jcem-34-5-819","article-title":"Plasma aldosterone and renin activity during the menstrual cycle","volume":"34","author":"Katz","year":"1972","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.02.003_bib0750","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1210\/jc.2006-1154","article-title":"Relationship between aldosterone and progesterone in the human menstrual cycle","volume":"91","author":"Szmuilowicz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.02.003_bib0755","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1210\/jc.2010-2918","article-title":"Effect of contraceptives on aldosterone\/renin ratio may vary according to the components of contraceptive, renin assay method, and possibly route of administration","volume":"96","author":"Ahmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.02.003_bib0760","article-title":"The importance of knowing the timing within the menstrual cycle in non-menopausal hypertensive women in the diagnostic workup for primary aldosteronism","volume":"27","author":"Fommei","year":"2015","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2016.02.003_bib0765","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/cen.12705","article-title":"Should aldosterone suppression tests be conducted during a particular phase of the menstrual cycle, and, if so, which phase? Results of a preliminary study","volume":"83","author":"Ahmed","year":"2015","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2016.02.003_bib0770","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1210\/jcem-63-4-1008","article-title":"Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives","volume":"63","author":"Derkx","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.02.003_bib0775","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0002-8703(84)90144-3","article-title":"Plasma renin substrate, renin activity, and aldosterone levels in a sample of oral contraceptive users from a community survey","volume":"107","author":"Goldhaber","year":"1984","journal-title":"Am Heart J"},{"key":"10.1016\/j.ando.2016.02.003_bib0780","doi-asserted-by":"crossref","first-page":"E340","DOI":"10.1210\/jc.2010-1355","article-title":"Are women more at risk of false-positive primary aldosteronism screening and unnecessary suppression testing than men?","volume":"96","author":"Ahmed","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.02.003_bib0785","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","article-title":"Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism","volume":"40","author":"Mulatero","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.ando.2016.02.003_bib0790","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0889-8529(05)70283-8","article-title":"Pheochromocytoma and primary aldosteronism: diagnostic approaches","volume":"26","author":"Young","year":"1997","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.ando.2016.02.003_bib0795","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1210\/jcem-63-5-1126","article-title":"Effect of sodium balance and calcium channel-blocking drugs on plasma aldosterone responses to infusion of angiotensin II in normal subjects and patients with essential hypertension","volume":"63","author":"Anderson","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.02.003_bib0800","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2265.2002.01613.x","article-title":"Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism","volume":"57","author":"Seifarth","year":"2002","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2016.02.003_bib0805","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1373\/clinchem.2008.118000","article-title":"Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement","volume":"55","author":"Campbell","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.ando.2016.02.003_bib0810","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/clpt.1980.221","article-title":"Effects of two nonsteroidal anti-inflammatory drugs, indomethacin and oxaprozin, on the kidney","volume":"28","author":"Mitnick","year":"1980","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ando.2016.02.003_bib0815","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1210\/jc.2010-2603","article-title":"Effects of two selective serotonin reuptake inhibitor antidepressants, sertraline and escitalopram, on aldosterone\/renin ratio in normotensive depressed male patients","volume":"96","author":"Ahmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2016.02.003_bib0820","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1530\/eje.0.1500329","article-title":"Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication","volume":"150","author":"Seiler","year":"2004","journal-title":"Eur J Endocr"},{"key":"10.1016\/j.ando.2016.02.003_bib0825","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0272-6386(01)80117-7","article-title":"Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio","volume":"37","author":"Gallay","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ando.2016.02.003_bib0830","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/cen.12882","article-title":"beta-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension","volume":"84","author":"Browne","year":"2016","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2016.02.003_bib0835","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/1470320312463833","article-title":"Screening for primary aldosteronism in a primary care unit","volume":"14","author":"Volpe","year":"2013","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.ando.2016.02.003_bib0840","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/HJH.0b013e3283656b54","article-title":"Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism","volume":"32","author":"Jansen","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/j.ando.2016.02.003_bib0845","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","article-title":"Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009","volume":"58","author":"Nishikawa","year":"2011","journal-title":"Endocr J"},{"key":"10.1016\/j.ando.2016.02.003_bib0850","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1530\/EJE-11-0914","article-title":"Confirmatory testing in primary aldosteronism: extensive medication switching is not needed in all patients","volume":"166","author":"Solar","year":"2012","journal-title":"Eur J Endocrinol"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426616000251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426616000251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:48:48Z","timestamp":1757717328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426616000251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0003426616000251"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2016.02.003","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SFE\/SFHTA\/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic steps","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2016.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}